000 | 01874 a2200529 4500 | ||
---|---|---|---|
005 | 20250515115550.0 | ||
264 | 0 | _c20080707 | |
008 | 200807s 0 0 eng d | ||
022 | _a1528-0012 | ||
024 | 7 |
_a10.1053/j.gastro.2008.02.060 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aElinav, Eran | |
245 | 0 | 0 |
_aRedirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. _h[electronic resource] |
260 |
_bGastroenterology _cJun 2008 |
||
300 |
_a2014-24 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBystander Effect |
650 | 0 | 4 |
_aCD28 Antigens _ximmunology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Movement |
650 | 0 | 4 |
_aColitis _xchemically induced |
650 | 0 | 4 |
_aColon _ximmunology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aForkhead Transcription Factors _xmetabolism |
650 | 0 | 4 |
_aHistocompatibility Antigens _ximmunology |
650 | 0 | 4 | _aImmunity, Mucosal |
650 | 0 | 4 |
_aImmunoglobulin Variable Region _ximmunology |
650 | 0 | 4 | _aImmunotherapy, Adoptive |
650 | 0 | 4 |
_aIntestinal Mucosa _ximmunology |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 | _aOxazolone |
650 | 0 | 4 |
_aPicrates _ximmunology |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xgenetics |
650 | 0 | 4 |
_aReceptors, IgG _ximmunology |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _ximmunology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTrinitrobenzenesulfonic Acid |
700 | 1 | _aWaks, Tova | |
700 | 1 | _aEshhar, Zelig | |
773 | 0 |
_tGastroenterology _gvol. 134 _gno. 7 _gp. 2014-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.gastro.2008.02.060 _zAvailable from publisher's website |
999 |
_c17921766 _d17921766 |